|
This is an index of adverse event reports related to Progesterone. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (25)
Cases resulting in a serious event (23)
Cases resulting in life threatening events (1)
Cases resulting in hospitalization (12)
Cases resulting in disability (2)
Cases resulting in other serious reactions (11)
Adverse event in female receiving Progesterone
Reported by a lawyer from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Basedow's Disease, Dysphagia, Dyspnoea, Nausea, Hypoaesthesia, Arrhythmia, Paraesthesia, Anxiety, Weight Increased, Chest Pain, Insomnia, Blood Cholesterol Increased, Depression, Bradycardia, Muscle Spasms
Suspect drug(s):
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1998-01-01
Progesterone
Conjugated Estrogens
Medroxyprogesterone Acetate
Adverse event in 33 year old female receiving Progesterone
Reported by a physician from United States on 2007-10-23
Patient: 33 year old female, weighing 55.3 kg (121.7 pounds)
Adverse reactions / side effects: Fatigue, Nausea, Headache, Loss of Consciousness
Suspect drug(s):
Progesterone
Adverse event in 35 year old female receiving Progesterone
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-30
Patient: 35 year old female
Adverse reactions / side effects: Post Abortion Haemorrhage, Retained Products of Conception, SEX Chromosome Abnormality, Abortion Induced, Drug Exposure Before Pregnancy
Suspect drug(s):
Chorionic Gonadotrophin
Indication: in Vitro Fertilisation
Progesterone
Dosage: 400 mg bid
Indication: in Vitro Fertilisation
Follitropin Beta
Propofol
Indication: in Vitro Fertilisation
Leuprolide Acetate
Indication: in Vitro Fertilisation
Start date: 2000-06-01
Alfentanyl Hydrochloride
Indication: in Vitro Fertilisation
Adverse event in 60 year old female receiving Progesterone
Reported by a physician from France on 2007-07-02
Patient: 60 year old female
Adverse reactions / side effects: Retinal Vein Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Progesterone
Indication: Ill-Defined Disorder
Start date: 1993-01-01
End date: 2006-01-01
Estradiol
Indication: Ill-Defined Disorder
Start date: 1993-01-01
End date: 2006-01-01
Adverse event in 51 year old female receiving Progesterone
Reported by a lawyer from United States on 2007-06-12
Patient: 51 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Indication: Menopausal Symptoms
Estradiol
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Climara
Indication: Menopausal Symptoms
Progesterone
Indication: Menopausal Symptoms
Adverse event in female receiving Progesterone
Reported by a individual with unspecified qualification from Czech Republic on 2007-06-01
Patient: female
Adverse reactions / side effects: Ectopic Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Progesterone
Dosage: daily dose: 600 milligram(s)
Indication: Ill-Defined Disorder
Start date: 2007-04-02
End date: 2007-05-03
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 150 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-22
End date: 2007-03-22
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 150 international unit(s)
Start date: 2007-03-22
End date: 2007-03-28
Follitropin Beta
Dosage: daily dose: 100 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-29
End date: 2007-03-30
Ganirelix Acetate Injection
Dosage: daily dose: .25 milligram(s)
Indication: Ill-Defined Disorder
Start date: 2007-03-26
End date: 2007-03-31
Chorionic Gonadotropin
Dosage: daily dose: 10000 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-31
End date: 2007-03-31
Other drugs received by patient: Mamavit; Propofol; Alfentanil
Adverse event in 33 year old female receiving Progesterone
Reported by a individual with unspecified qualification from Denmark on 2007-06-01
Patient: 33 year old female
Adverse reactions / side effects: Ectopic Pregnancy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Follitropin Beta
Dosage: 200 iu; subcutaneous
Indication: Ovarian Hyperfunction
Start date: 2007-04-08
End date: 2007-04-16
Marvelon
Dosage: 1df; oral
Administration route: Oral
Indication: Ovarian Hyperfunction
Start date: 2007-03-14
End date: 2007-04-03
Ganirelix Acetate Injection
Dosage: 0.25 mg; subcutaneous
Start date: 2007-04-12
End date: 2007-04-16
Chorionic Gonadotropin
Dosage: 10000 iu, subcutaneous
Indication: Ovulation Induction
Start date: 2007-04-16
End date: 2007-04-16
Progesterone
Adverse event in female receiving Progesterone
Reported by a individual with unspecified qualification from Taiwan, Province of China on 2007-05-29
Patient: female
Adverse reactions / side effects: Ectopic Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Progestan
Dosage: daily dose: 600 milligram(s)
Indication: Ill-Defined Disorder
Start date: 2007-04-07
End date: 2007-04-24
Progesterone
Dosage: daily dose: 100 milligram(s)
Indication: Ill-Defined Disorder
Start date: 2007-04-25
End date: 2007-04-26
Progesterol INJ
Dosage: daily dose: 50 milligram(s)
Start date: 2007-04-27
End date: 2007-05-03
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 100 iu/kilogram
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-29
End date: 2007-03-29
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 150 international unit(s)
Start date: 2007-03-29
End date: 2007-04-04
Puregon
Dosage: daily dose: 150 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-04-05
End date: 2007-04-05
Orgalutran
Dosage: daily dose: .25 milligram(s)
Indication: Prophylaxis
Start date: 2007-04-02
End date: 2007-04-05
Pregnyl
Dosage: daily dose: 10000 international unit(s)
Indication: Ovulation Induction
Start date: 2007-04-05
End date: 2007-04-05
Adverse event in female receiving Progesterone
Reported by a lawyer from United States on 2007-05-22
Patient: female, weighing 79.5 kg (174.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1988-01-01
End date: 1999-04-21
Prempro
Progesterone
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1988-01-01
End date: 1999-04-21
Adverse event in female receiving Progesterone
Reported by a individual with unspecified qualification from Czech Republic on 2007-05-21
Patient: female
Adverse reactions / side effects: Ectopic Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Progesterone
Dosage: daily dose: 600 milligram(s)
Indication: Ill-Defined Disorder
Start date: 2007-04-02
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 150 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-22
End date: 2007-03-22
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 150 international unit(s)
Start date: 2007-03-22
End date: 2007-03-28
Follitropin Beta
Dosage: daily dose: 100 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-29
End date: 2007-03-30
Ganirelix Acetate Injection
Dosage: daily dose: .25 milligram(s)
Indication: Ill-Defined Disorder
Start date: 2007-03-26
End date: 2007-03-31
Chorionic Gonadotropin
Dosage: daily dose: 10000 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-31
End date: 2007-03-31
Other drugs received by patient: Mamavit; Propofol; Alfentanil
Adverse event in female receiving Progesterone
Reported by a individual with unspecified qualification from Netherlands on 2007-05-21
Patient: female
Adverse reactions / side effects: Drug Exposure Before Pregnancy, Ectopic Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Progesterone
Dosage: daily dose: 600 milligram(s)
Indication: Ill-Defined Disorder
Start date: 2007-03-27
End date: 2007-05-02
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: unknown
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-16
End date: 2007-03-16
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: unknown
Start date: 2007-03-16
End date: 2007-03-22
Follintropin Beta
Dosage: daily dose: 200 international unit(s)
Indication: Ill-Defined Disorder
Start date: 2007-03-23
End date: 2007-03-25
Ganirelix Acetate Injection
Dosage: daily dose: .25 milligram(s)
Indication: Prophylaxis
Start date: 2007-03-20
End date: 2007-03-25
Chorionic Gonadotropin
Dosage: daily dose: 10000 international unit(s)
Indication: Ovulation Induction
Start date: 2007-03-25
End date: 2007-03-25
Adverse event in female receiving Progesterone
Reported by a individual with unspecified qualification from Czech Republic on 2007-05-14
Patient: female
Adverse reactions / side effects: Ectopic Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Progesterone
Dosage: daily dose: 600 milligram(s)
Indication: Luteal Phase Deficiency
Start date: 2007-03-22
End date: 2007-04-08
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 150 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-13
End date: 2007-03-19
Ganirelix Acetate Injection
Dosage: daily dose: .25 milligram(s)
Indication: Prophylaxis
Start date: 2007-03-17
End date: 2007-03-19
Chorionic Gonadotropin
Dosage: daily dose: 10000 international unit(s)
Indication: Ovulation Induction
Start date: 2007-03-20
End date: 2007-03-20
Other drugs received by patient: Alfentanil; Propofol
Adverse event in female receiving Progesterone
Reported by a individual with unspecified qualification from Czech Republic on 2007-05-08
Patient: female
Adverse reactions / side effects: Ectopic Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Progesterone
Dosage: daily dose: unknown
Indication: Luteal Phase Deficiency
Start date: 2007-03-22
End date: 2007-04-08
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 150 international unit(s)
Indication: Ovarian Hyperstimulation Syndrome
Start date: 2007-03-13
End date: 2007-03-19
Ganirelix Acetate Injection
Dosage: daily dose: .25 milligram(s)
Indication: Prophylaxis
Start date: 2007-03-17
End date: 2007-03-19
Chorionic Gonadotropin
Dosage: daily dose: 10000 international unit(s)
Indication: Ovulation Induction
Start date: 2007-03-20
End date: 2007-03-20
Other drugs received by patient: Alfentanil; Propofol
Adverse event in 58 year old male receiving Progesterone
Reported by a individual with unspecified qualification from United States on 2007-04-20
Patient: 58 year old male, weighing 72.6 kg (159.6 pounds)
Adverse reactions / side effects: Night Sweats, Lymphadenopathy, Deafness, Breast Cancer in Situ, Chemotherapy, Hot Flush, Breast Cyst, Uterine Leiomyoma, Posterior Capsulotomy, Maculopathy, Tendonitis, Breast Cancer, Back Pain, Radiotherapy, Breast Mass, Cataract Operation, Diverticulum, Sleep Disorder, Disturbance in Attention, Breast Necrosis, Vitrectomy, Myalgia, Fibrocystic Breast Disease, Uterine Cervical Squamous Metaplasia, Depression, Endometrial Disorder, Scoliosis, Cataract, Musculoskeletal Pain, Breast Dysplasia, Anxiety, Arthralgia, Sexual Dysfunction, Memory Impairment, Spinal Osteoarthritis
Suspect drug(s):
Estraderm
Dosage: 0.05 mg
Indication: Hormone Replacement Therapy
Start date: 1990-08-01
End date: 1990-11-01
MPA
Dosage: 10mg qd
Indication: Hormone Replacement Therapy
Start date: 1990-08-31
End date: 1990-09-01
Premarin
Dosage: .625mg + 0.3mg
Indication: Hormone Replacement Therapy
Start date: 1990-12-01
End date: 1991-02-01
Estratest H.s.
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1991-03-01
End date: 1996-08-01
Cycrin
Indication: Hormone Replacement Therapy
Start date: 1994-02-01
End date: 1994-08-01
Prempro
Dosage: .625mg/2.5mg
Indication: Hormone Replacement Therapy
Start date: 1994-02-01
End date: 2000-03-01
Prempro
Dosage: 0.625mg/5mg
Provera
Indication: Hormone Replacement Therapy
Start date: 1990-12-01
End date: 1996-08-01
Android
Dosage: 10
Start date: 1996-12-31
Android
Dosage: 10
Start date: 1997-03-17
Progesterone
Dosage: 10 mg, qd
Start date: 1990-08-31
Other drugs received by patient: Aspirin; Prozac; Ritalin; Adderall 10; Effexor; Levox; Wellbutrin; Zoloft; Serzone; Ginkgo Biloba; Ginseng
Adverse event in female receiving Progesterone
Reported by a consumer/non-health professional from United States on 2007-04-09
Patient: female
Adverse reactions / side effects: Blood Pressure Increased, Anxiety, Limited Symptom Panic Attack, Drug Ineffective, Anger, Dizziness, Homicidal Ideation
Suspect drug(s):
Premarin
Administration route: Oral
Indication: Menopause
Start date: 2000-01-01
Premarin
Dosage: 0.3mg
Administration route: Oral
Start date: 2005-01-01
End date: 2005-01-01
Premarin
Dosage: 0.625mg
Administration route: Oral
Start date: 2005-01-01
Premarin
Dosage: .9mg
Administration route: Oral
Start date: 2005-01-01
Progesterone
Adverse event in 41 year old female receiving Progesterone
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-04-06
Patient: 41 year old female, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Haemorrhage, Ectopic Pregnancy
Suspect drug(s):
Cosopt
Indication: Intraocular Pressure Increased
Start date: 2003-06-04
Progesterone
Start date: 2007-02-03
End date: 2007-02-26
Other drugs received by patient: Levothyroxine Sodium; Ferrous Sulfate; Latanoprost; Travoprost; Timolol; Travoprost; Folic Acid and Iron (Unspecified); Vitamins (Unspecified)
Adverse event in 35 year old female receiving Progesterone
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-03-15
Patient: 35 year old female
Adverse reactions / side effects: SEX Chromosome Abnormality, Haemorrhage, Abortion Induced, Drug Exposure Before Pregnancy
Suspect drug(s):
Diprivan
Indication: in Vitro Fertilisation
Start date: 2000-06-01
Pregnyl
Indication: in Vitro Fertilisation
Start date: 2000-06-01
Progesterone
Indication: in Vitro Fertilisation
Start date: 2000-06-01
Prostap
Indication: in Vitro Fertilisation
Start date: 2000-06-01
Puregon
Start date: 2000-06-01
Rapifen
Indication: in Vitro Fertilisation
Start date: 2000-06-01
Adverse event in 65 year old female receiving Progesterone
Reported by a health professional (non-physician/pharmacist) from France on 2007-03-13
Patient: 65 year old female, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Bone Marrow Failure, Pancytopenia, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Xalatan
Dosage: text:2 dose forms-freq:daily
Start date: 2006-01-01
End date: 2006-03-29
Piroxicam
Administration route: Oral
Progesterone
Administration route: Oral
Flecainide Acetate
Administration route: Oral
Start date: 2003-01-15
End date: 2006-03-29
Ginkgo Biloba Leaf Extract
Dosage: text:3 dose forms-freq:daily
Administration route: Oral
Start date: 2000-01-01
End date: 2006-03-29
Alphagan
Dosage: text:2 dose forms-freq:daily
Start date: 2006-01-01
End date: 2006-03-29
Adverse event in 35 year old female receiving Progesterone
Reported by a individual with unspecified qualification from United Kingdom on 2007-03-09
Patient: 35 year old female
Adverse reactions / side effects: Retained Products of Conception, SEX Chromosome Abnormality, Abortion Induced, Drug Exposure Before Pregnancy, Vaginal Haemorrhage
Suspect drug(s):
Chorionic Gonadotropin
Indication: in Vitro Fertilisation
Progesterone
Dosage: 400 mg bid vaginal
Indication: in Vitro Fertilisation
Follitropin Beta
Propofol
Dosage: intravenous (nos)
Indication: in Vitro Fertilisation
Leuprolide Acetate
Indication: in Vitro Fertilisation
Start date: 2000-06-01
Alfentanil
Dosage: intravenous (nos)
Indication: in Vitro Fertilisation
Adverse event in 35 year old female receiving Progesterone
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-03-09
Patient: 35 year old female
Adverse reactions / side effects: SEX Chromosome Abnormality, Abortion Induced, Uterine Haemorrhage
Suspect drug(s):
Progesterone
Dosage: daily dose: 800 milligram(s)
Indication: in Vitro Fertilisation
Start date: 2000-06-01
End date: 2000-06-01
Diprivan
Dosage: daily dose: 240 milligram(s)
Indication: in Vitro Fertilisation
Start date: 2000-06-01
End date: 2000-06-01
Pregnyl
Dosage: daily dose: 1000 international unit(s)
Indication: in Vitro Fertilisation
Start date: 2000-06-01
End date: 2000-06-01
Prostap
Dosage: daily dose: 3.75 milligram(s)
Indication: in Vitro Fertilisation
Start date: 2000-06-01
Purgeon
Dosage: daily dose: 100 international unit(s)
Indication: in Vitro Fertilisation
Start date: 2000-06-01
End date: 2000-06-01
Rapifen
Dosage: daily dose: 600 milligram(s)
Indication: in Vitro Fertilisation
Start date: 2000-06-01
End date: 2000-06-01
Adverse event in 41 year old female receiving Progesterone
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-03-09
Patient: 41 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Haemorrhage, Ectopic Pregnancy
Suspect drug(s):
Cosopt
Indication: Intraocular Pressure Increased
Start date: 2003-06-04
Progesterone
Start date: 2007-02-03
Other drugs received by patient: Levothyroxine Sodium; Ferrous Sulfate; Latanoprost; Travoprost; Timolol; Travoprost; Folic Acid and Iron (Unspecified); Vitamins (Unspecified)
Adverse event in female receiving Progesterone
Reported by a individual with unspecified qualification from Norway on 2007-02-21
Patient: female
Adverse reactions / side effects: Ectopic Pregnancy
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Progesterone
Dosage: daily dose: 600 milligram(s)
Indication: in Vitro Fertilisation
Start date: 2006-12-01
End date: 2006-12-03
ORG 36286 and Placebo OR Puregon and Placebo
Dosage: daily dose: 200 international unit(s)
Indication: Ill-Defined Disorder
Start date: 2006-11-19
End date: 2006-11-25
Follitropin Beta
Dosage: daily dose: 200 international unit(s)
Indication: Ill-Defined Disorder
Start date: 2006-11-26
End date: 2006-11-29
Ganirelix Acetate Injection
Dosage: daily dose: .25 milligram(s)
Indication: Ill-Defined Disorder
Start date: 2006-11-23
End date: 2006-11-29
Chorionic Gonadotropin
Dosage: daily dose: 10000 international unit(s)
Indication: Ovulation Induction
Start date: 2006-11-29
End date: 2006-11-29
Adverse event in 65 year old female receiving Progesterone
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-21
Patient: 65 year old female
Adverse reactions / side effects: Tonsillitis, Pancytopenia, Bone Marrow Failure, Pyrexia, Inflammation
Adverse event resulted in: hospitalization
Suspect drug(s):
Progesterone
Dosage: daily dose: 100 milligram(s)
Administration route: Oral
Indication: Ill-Defined Disorder
End date: 2006-03-29
Alphagan
Dosage: daily dose: 2 dosage form
Indication: Ill-Defined Disorder
Start date: 2006-01-01
End date: 2006-03-29
Tanakan
Dosage: daily dose: 3 dosage form
Administration route: Oral
Indication: Ill-Defined Disorder
Start date: 2000-01-01
End date: 2006-03-29
Flecainide Acetate
Dosage: daily dose: 200 milligram(s)
Administration route: Oral
Indication: Ill-Defined Disorder
Start date: 2003-01-15
End date: 2006-03-29
Xalatan
Dosage: daily dose: 2 dosage form
Indication: Ill-Defined Disorder
Start date: 2006-01-01
End date: 2006-03-29
Piroxicam
Dosage: daily dose: 2 dosage form
Administration route: Oral
Indication: Ill-Defined Disorder
Start date: 2006-01-01
End date: 2006-03-29
Piroxicam
Dosage: daily dose: 200 milligram(s)
Administration route: Oral
End date: 2006-03-01
Adverse event in 31 year old female receiving Progesterone
Reported by a individual with unspecified qualification from United States on 2007-02-20
Patient: 31 year old female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Viral Infection, Eosinophilic Pneumonia, Gastric Disorder, Abortion Spontaneous, Laboratory Test Abnormal, Drug Exposure During Pregnancy, Heart Rate Increased, Pregnancy
Adverse event resulted in: disablity
Suspect drug(s):
Progesterone
Adverse event in 55 year old female receiving Progesterone
Reported by a consumer/non-health professional from Spain on 2007-01-23
Patient: 55 year old female, weighing 110.0 kg (242.0 pounds)
Adverse reactions / side effects: Phlebitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Sotalol Hydrochloride
Dosage: 160 mg, 1x/day
Administration route: Oral
Aceclofenac
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Rheumatoid Arthritis
Cotareg ^rhone-Poulenc Rorer^
Administration route: Oral
Provames
Dosage: 1 df, 1x/day
Administration route: Oral
Start date: 1998-01-01
End date: 2005-10-26
Novatrex ^lederle^
Dosage: 5 mg, 1x/week
Administration route: Oral
Indication: Rheumatoid Arthritis
Progesterone
Dosage: 100 mg, 1x/day
Administration route: Oral
Start date: 1998-01-01
End date: 2005-10-26
Tramadol HCL
Administration route: Oral
|
